![GALYM IMANBAYEV](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
GALYM IMANBAYEV
Direktor/Vorstandsmitglied bei Kirilys Therapeutics, Inc.
Aktive Positionen von GALYM IMANBAYEV
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lightspeed Management Co LLC
![]() Lightspeed Management Co LLC Investment ManagersFinance Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners. | Private Equity Investor | 01.01.2020 | - |
Kirilys Therapeutics, Inc.
![]() Kirilys Therapeutics, Inc. Medical/Nursing ServicesHealth Services Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von GALYM IMANBAYEV
Ausbildung von GALYM IMANBAYEV
Stanford University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Private Equity Investor | 1 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sektoral
Finance | 2 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Lightspeed Management Co LLC
![]() Lightspeed Management Co LLC Investment ManagersFinance Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners. | Finance |
Kirilys Therapeutics, Inc.
![]() Kirilys Therapeutics, Inc. Medical/Nursing ServicesHealth Services Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation. | Health Services |
- Börse
- Insiders
- GALYM IMANBAYEV
- Erfahrung